NZ765690A - Aryl receptor modulators and methods of making and using the same - Google Patents
Aryl receptor modulators and methods of making and using the sameInfo
- Publication number
- NZ765690A NZ765690A NZ765690A NZ76569015A NZ765690A NZ 765690 A NZ765690 A NZ 765690A NZ 765690 A NZ765690 A NZ 765690A NZ 76569015 A NZ76569015 A NZ 76569015A NZ 765690 A NZ765690 A NZ 765690A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methods
- making
- same
- receptor modulators
- compounds
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 abstract 1
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 102100037850 Interferon gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity,methods of treating inflammatory conditions such as Crohn’s disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-γ in a subject.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462017959P | 2014-06-27 | 2014-06-27 | |
US201462056054P | 2014-09-26 | 2014-09-26 | |
NZ727475A NZ727475B2 (en) | 2015-06-26 | Aryl receptor modulators and methods of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ765690A true NZ765690A (en) | 2023-07-28 |
Family
ID=87654783
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ765690A NZ765690A (en) | 2014-06-27 | 2015-06-26 | Aryl receptor modulators and methods of making and using the same |
NZ765691A NZ765691A (en) | 2014-06-27 | 2015-06-26 | Aryl receptor modulators and methods of making and using the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ765691A NZ765691A (en) | 2014-06-27 | 2015-06-26 | Aryl receptor modulators and methods of making and using the same |
Country Status (1)
Country | Link |
---|---|
NZ (2) | NZ765690A (en) |
-
2015
- 2015-06-26 NZ NZ765690A patent/NZ765690A/en unknown
- 2015-06-26 NZ NZ765691A patent/NZ765691A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ765691A (en) | 2023-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021015632A (en) | Aryl receptor modulators and methods of making and using the same. | |
MX2020014121A (en) | Insulin receptor partial agonists. | |
MX2021009309A (en) | Modulation of complement activity. | |
MX2017013562A (en) | Microbiome regulators and related uses thereof. | |
MX2017011997A (en) | Piperazine carbamates and methods of making and using same. | |
EA201991598A1 (en) | COMPOUNDS MODULATING THE Aryl Hydrocarbon Receptor (AhR) | |
MY193723A (en) | Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1 | |
PH12016501441A1 (en) | Chimeric alkaline phosphate-like proteins | |
PH12017500660A1 (en) | Novel compositions, uses and methods for making them | |
PH12017501077A1 (en) | Compositions and methods for antibodies targeting bmp6 | |
MY192588A (en) | Pharmaceutical compounds | |
GB2541571A (en) | Pharmaceutical compositions | |
MX2017004838A (en) | Interleukin-15 compositions and uses thereof. | |
MX2022000053A (en) | Modulators of sestrin-gator2 interaction and uses thereof. | |
WO2016100619A3 (en) | Treatment and diagnosis of cancer | |
EA201991599A1 (en) | COMPOUNDS MODULATING THE Aryl Hydrocarbon Receptor (AhR) | |
IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
EA201991600A1 (en) | COMPOUNDS MODULATING THE Aryl Hydrocarbon Receptor (AhR) | |
MX2018000352A (en) | Substituted 4-azaindoles and their use as glun2b receptor modulators. | |
MX2016009590A (en) | Apilimod compositions and methods for using same. | |
WO2015120138A3 (en) | AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF | |
WO2016040824A3 (en) | METHODS OF IDENTIFYING MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USE OF SAME TO MODULATE mTORC1 | |
MX2018005987A (en) | Heterocyclic compounds for the treatment of disease. | |
PL3122367T3 (en) | Compositions based on saffron for the prevention and/or treatment of degenerative eye disorders. | |
EA201791450A1 (en) | 3,5-DIAMINOPYRAZOLES KINASE INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUN 2025 BY COMPUTER PACKAGES INC Effective date: 20240530 |